FBRX Forte Biosciences, Inc.Stock Price & Overview
$0.77-0.02 (-2.04%)3:44 PM 09/22/23
NASDAQ | $USD | Post-Market: $0.74 -0.03 (-3.90%) 7:39 PM
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.